MCC
JAZZ icon

Money Concepts Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Money Concepts Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-691
Closed -$110K – 1750
2022
Q4 		$110K Buy
691
+27
+4% +$3.96K ﹤0.01% 929
2022
Q3 		$89K Sell
664
-48
-7% -$7.3K 0.01% 593
2022
Q2 		$113K Hold
712
– – 0.01% 539
2022
Q1 		$111K Buy
+712
New +$103K 0.01% 948

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Money Concepts Capital's JAZZ Position: Q1 2023 in Review

Money Concepts Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 691 shares — an estimated $110K sold.

Money Concepts Capital first reported a position in JAZZ in Q1 2022 and held it in 4 quarters. The position peaked at $113K in Q2 2022. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

  • Money Concepts Capital reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 691 Jazz Pharmaceuticals shares in Q1 2023, an estimated $110K.
  • Money Concepts Capital first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Jazz Pharmaceuticals position peaked at $113K in Q2 2022.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.